Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Watz

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Pneumologie (Stuttgart, Germany)|July 17, 2004
[Bronchioloalveolar carcinoma of the lung associated with a highly positive pANCA-titer and clinical signs of microscopic polyangiitis]H Watz, P Hammerl, C Matter, et al.
Respiratory Medicine|August 5, 2009
Peak inspiratory flow through the Genuair inhaler in patients with moderate or severe COPDH Magnussen, H Watz, I Zimmermann, et al.
The European Respiratory Journal|August 1, 2009
SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjectsO Holz, S Khalilieh, A Ludwig-Sengpiel, et al.
Psychological Medicine|September 2, 2009
Specificity of cognitive biases in patients with current depression and remitted depression and in patients with asthmaA Fritzsche, B Dahme, I H Gotlib, et al.
Pneumologie (Stuttgart, Germany)|September 4, 2015
[Expert meeting obstructive airway disease measuring and evaluating in COPD]J Lorenz, R Bals, R Ewert, et al.
Pneumologie (Stuttgart, Germany)|July 15, 2020
[Technological Innovations in Pulmonology - Examples from Diagnostics and Therapy]W Randerath, M Dreher, D Gompelmann, et al.
Pulmonary Pharmacology & Therapeutics|February 15, 2015
The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPDA M Kirsten, K Förster, E Radeczky, et al.
Pneumologie (Stuttgart, Germany)|October 11, 2016
[Expert Meeting on COPD: Personalized Treatment of COPD - Wishful Thinking or Reality?]J Lorenz, R Bals, R Ewert, et al.
Pneumologie (Stuttgart, Germany)|May 16, 2017
[Exacerbation of COPD]J Lorenz, R Bals, M Dreher, et al.
BMJ Open Respiratory Research|December 10, 2016
Angiopoietin-like protein 4 and cardiovascular function in COPDB Waschki, A M Kirsten, O Holz, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Pneumologie (Stuttgart, Germany)|July 17, 2004
[Bronchioloalveolar carcinoma of the lung associated with a highly positive pANCA-titer and clinical signs of microscopic polyangiitis]H Watz, P Hammerl, C Matter, et al.
Respiratory Medicine|August 5, 2009
Peak inspiratory flow through the Genuair inhaler in patients with moderate or severe COPDH Magnussen, H Watz, I Zimmermann, et al.
The European Respiratory Journal|August 1, 2009
SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjectsO Holz, S Khalilieh, A Ludwig-Sengpiel, et al.
Psychological Medicine|September 2, 2009
Specificity of cognitive biases in patients with current depression and remitted depression and in patients with asthmaA Fritzsche, B Dahme, I H Gotlib, et al.
Pneumologie (Stuttgart, Germany)|September 4, 2015
[Expert meeting obstructive airway disease measuring and evaluating in COPD]J Lorenz, R Bals, R Ewert, et al.
Pneumologie (Stuttgart, Germany)|July 15, 2020
[Technological Innovations in Pulmonology - Examples from Diagnostics and Therapy]W Randerath, M Dreher, D Gompelmann, et al.
Pulmonary Pharmacology & Therapeutics|February 15, 2015
The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPDA M Kirsten, K Förster, E Radeczky, et al.
Pneumologie (Stuttgart, Germany)|October 11, 2016
[Expert Meeting on COPD: Personalized Treatment of COPD - Wishful Thinking or Reality?]J Lorenz, R Bals, R Ewert, et al.
Pneumologie (Stuttgart, Germany)|May 16, 2017
[Exacerbation of COPD]J Lorenz, R Bals, M Dreher, et al.
BMJ Open Respiratory Research|December 10, 2016
Angiopoietin-like protein 4 and cardiovascular function in COPDB Waschki, A M Kirsten, O Holz, et al.
Pageof 4